Journal of Clinical Microbiology · 2011 · 89 citations · 26 references
Life SciencesMicrobiologyMolecular BiologyDiagnostic MicrobiologyMycologyPulmonologyFungal DiagnosticsFungal IdentificationFungal InfectionsPathogen DetectionFungal DetectionInvasive Aspergillosis DiagnosisMolecular Detection AssaysQuantitative Pcr DetectionReal-time Polymerase Chain Reaction (Pcr)Species-specific AssaysSpecies-specific DetectionSpecies-specific Identification
Diagnosis of invasive pulmonary aspergillosis (IPA) remains a major challenge to clinical microbiology laboratories. We developed rapid and sensitive quantitative PCR (qPCR) assays for genus- and species-specific identification of Aspergillus infections by use of TaqMan technology. In order to validate these assays and understand their potential diagnostic utility, we then performed a blinded study of bronchoalveolar lavage (BAL) fluid specimens from well-characterized models of IPA with the four medically important species. A set of real-time qPCR primers and probes was developed by utilizing unique ITS1 regions for genus- and species-specific detection of the four most common medically important Aspergillus species (Aspergillus fumigatus, A. flavus, A. niger, and A. terreus). Pan-Aspergillus and species-specific qPCRs with BAL fluid were more sensitive than culture for detection of IPA caused by A. fumigatus in untreated (P < 0.0007) and treated (P ≤ 0.008) animals, respectively. For infections caused by A. terreus and A. niger, culture and PCR amplification from BAL fluid yielded similar sensitivities for untreated and treated animals. Pan-Aspergillus PCR was more sensitive than culture for detection of A. flavus in treated animals (P = 0.002). BAL fluid pan-Aspergillus and species-specific PCRs were comparable in sensitivity to BAL fluid galactomannan (GM) assay. The copy numbers from the qPCR assays correlated with quantitative cultures to determine the pulmonary residual fungal burdens in lung tissue. Pan-Aspergillus and species-specific qPCR assays may improve the rapid and accurate identification of IPA in immunocompromised patients.
26
Ben de Pauw, Thomas J. Walsh, J. Peter Donnelly et al. · Clinical Infectious Diseases · 2008 · 4.9K citations · Full text
Dimitrios P. Kontoyiannis, Kieren A. Marr, Benjamin J. Park et al. · Clinical Infectious Diseases · 2010 · 1.4K citations · Full text
Kieren A. Marr, S. Arunmozhi Balajee, Lisa McLaughlin et al. · The Journal of Infectious Diseases · 2004 · 482 citations
S. Arunmozhi Balajee, Rui Kano, John W. Baddley et al. · Journal of Clinical Microbiology · 2009 · 300 citations · Full text